Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,120
+120 (1.00%)
Jul 11, 2025, 3:30 PM KST

Chabiotech Revenue

Chabiotech had revenue of 304.14B KRW in the quarter ending March 31, 2025, with 30.87% growth. This brings the company's revenue in the last twelve months to 1.12T, up 17.57% year-over-year. In the year 2024, Chabiotech had annual revenue of 1.05T with 9.55% growth.

Revenue (ttm)
1,116.79B
Revenue Growth
+17.57%
P/S Ratio
0.83
Revenue / Employee
4.02B
Employees
278
Market Cap
922.15B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 1,045.05B 91.10B 9.55%
Dec 31, 2023 953.95B 109.37B 12.95%
Dec 31, 2022 844.58B 117.11B 16.10%
Dec 31, 2021 727.48B 62.76B 9.44%
Dec 31, 2020 664.72B 130.11B 24.34%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
PharmaResearch 392.31B
LigaChem Biosciences 146.42B
Revenue Rankings